Applicability aspects of transition metal-catalyzed aromatic amination protocols in medicinal chemistry

Advanced Synthesis and Catalysis

Volumn 349, Issue 14-15, 2007, Pages 2286-2300

  Tasler, Stefan ^a   Mies, Jan ^a   Lang, Martin ^a  

^a 4SC AG   (Germany)

Author keywords

Amination; Copper; Cross coupling; Homogeneous catalysis; Medicinal chemistry; Palladium

Indexed keywords

EID: 36048965181     PISSN: 16154150     EISSN: 15213897     Source Type: Journal    
DOI: 10.1002/adsc.200700133     Document Type: Article

References (67)

1. a) J. Louie, J. F. Hartwig, Tetrahedron Lett. 1995, 36, 3609-3612;
2. b) A. S. Guram, R. A. Rennels, S. L. Buchwald, Angew. Chem. 1995, 107, 1456-1459;
3. Angew. Chem. Int. Ed. Engl. 1995, 34, 1348-1350.
4. For review articles, see : a) J. F. Hartwig, Angew. Chem. 1998, 110, 2154-2177;
5. Angew. Chem. Int. Ed. Engl. 1998, 37, 2046-2067;
6. b) D. Prim, J.-M. Campagne, D. Joseph, B. Andrioletti, Tetrahedron 2002, 58, 2041-2075;
7. [3]
8. A. R. Muci, S. L. Buchwald, Top. Curr. Chem. 2002, 279, 131-209.
9. For a review, see : S. V. Ley, A. W Thomas, Angew. Chem. 2003, 115, 5558-5607;
10. Angew. Chem. Int. Ed. Engl. 2003, 42, 5400-5449.
11. A. Kiyomori, J.-F. Marcoux, S. L. Buchwald, Tetrahedron Lett. 1999, 40, 2657-2660.
12. X. Huang, K. W. Anderson, D. Zim, L. Jiang, A. Klapars, S. L. Buchwald, J. Am. Chem. Soc. 2003, 125, 6653-6655.
13. A. Klapars, J. C. Antilla, X. Huang, S. L. Buchwald, J. Am. Chem. Soc. 2001, 123, 1111-1129.
14. J. C. Antilla, A. Klapars, S. L. Buchwald, J. Am. Chem. Soc. 2002, 124, 11684-11688.
15. For Ni catalysis, see: a) J. P. Wolfe, S. L. Buchwald, J. Am. Chem. Soc. 1997, 119, 6054-6058;
16. b) C. Desmarets, R. Schneider, Y. Fort, J. Org. Chem. 2002, 67, 3029-3036;
17. c) E. Brenner, R. Schneider, Y. Fort, Tetrahedron 1999, 55, 12829-12842;
18. d) S. Tasler, B. H. Lipshutz, J. Org. Chem. 2003, 68, 1190-1199.
19. These demands are in clear contrast to those for industrial scale-up, examples of which using Pd-catalyzed amination reactions have been published most recently: elaborate fine-tuning of reaction conditions has to be performed to optimize yields, reduce side reactions, facilitate workup or decrease hazardous potential due to exothermic conversions and to decrease amount of catalyst to get dirt-cheap and thus economically attractive processes; see S. L. Buchwald, C. Mauger, G. Mignani, U. Scholz, Adv. Synth. Catal. 2006, 348, 23-39.
20. Several applications of catalyzed aromatic aminations in industrial research have been reported in the recent past, these - however - rather focused on the introduction of a defined amine into a special target molecule, including a detailed ligand screen and condition optimization, and did not aim at the generation of diverse libraries around one structural core unit. For a review on such applications with a focus on practical issues of the methodology, see B. Schlummer, U. Scholz, Adv. Synth. Catal. 2004, 346, 1599-1626.
21. S. Tasler, J. Kraus, A. Wuzik, O. Müller, A. Aschenbrenner, E. Cubero, R. Pascual, J.-R. Quintana-Ruiz, A. Dordal, R. Mercê, X. Codony, Bioorg. Med. Chem. Lett., submitted.
22. J. P. Wolfe, S. L. Buchwald, J. Org. Chem. 2000, 65, 1144-1157.
23. J. P. Wolfe, H. Tomori, J. P. Sadighi, J. Yin, S. L. Buchwald.y. Org. Chem. 2000, 65, 1158-1174.
24. 14], a competition experiment is presented in which 4-bromotoluene was aminated with morpholine in the presence of 4-chlorotoluene to proceed in favor of the aryl bromide in a 97:3 ratio.
25. M. S. Driver, J. F. Hartwig, J. Am. Chem. Soc. 1996, 118, 7217-7218.
26. J. F. Hartwig, M. Kawatsura, S. I. Hauck, K. H. Shaughnessy, L. M. Alcazar-Roman, J. Org. Chem. 1999, 64, 5575-5580.
27. For a test reaction using for example, benzylamine and 4-bromobenzonitrile using conditions A and B1, similar conversions were observed using either BINAP or DPPF (quantitative), but only traces of product formation were observed applying method C1.
28. M. S. Viciu, R. M. Kissling, E. D. Stevens, S. P. Nolan, Org. Lett. 2002, 4, 2229-2231.
29. Lancaster catalogue 2004/2005, sodium tert-pentoxide (OrderCode X15112) vs. sodium feri-butoxide (OrderCode X15051).
30. M. R. Netherton, G. C. Fu, Org. Lett. 2001, 3, 4295-4298;
31. [6] and J. E. Ney, J. P. Wolfe, J. Am. Chem. Soc. 2005, 127, 8644-8651.
32. R. Kuwano, M. Utsunomiya, J. F. Hartwig, J. Org. Chem. 2002, 67, 6479-6486.
33. Complete chemoselectivity for amination of the bromine site over chlorine site in 1,3-bromochlorobenzene under these conditions at room temperature has been reported: X. Z. Yan, J. Pawlas, T. Goodson III, J. F. Hartwig, J. Am. Chem. Soc. 2005, 127, 9105-9116.
34. A. Klapars, S. L. Buchwald, J. Am. Chem. Soc. 2002, 124, 14844-14845.
35. A. Klapars, X. Huang, S. L. Buchwald, J. Am. Chem. Soc. 2002, 124, 7421-7428.
36. [17]), NaOPh was prepared as an anhydrous base in contrast to a trihydrate as commercially available used within this work.
37. A. Ghosh, J. E. Sieser, M. Riou, W. Cai, L. Rivera-Ruiz, Org. Lett. 2003, 5, 2207-2210.
38. J. Yin, S. L. Buchwald, J. Am. Chem. Soc. 2002, 124, 6043-6048.
39. J. Yin, M. M. Zhao, M. A. Huffman, J. M. McNamara, Org. Lett. 2002, 4, 3481-3484.
40. For other Xantphos applications in couplings of bromoarenes and amides, carbamates, oxazolidinones and ureas, see: a) B. H. Yang, S. L. Buchwald, Org. Lett. 1999, 7, 35-37;
41. b) S. Cacchi, G. Fabrizi, A. Goggiamani, G. Zappia, Org. Lett. 2001, 3, 2539-2541;
42. c) G. A. Artamkina, A. G. Sergeev, I. P. Beletskaya, Tetrahedron Lett. 2001, 42, 4381-4384;
43. [31]; for arylation of anilines using Xantphos, see : e) B. C. Hamann, J. F. Hartwig, J. Am. Chem. Soc. 1998, 120, 3694-3703 (Xantphos = DPPX);
44. f) Y. Guarí, D. S. van Es, J. N. H. Reek, P. C. J. Kamer, P. W. N. M. van Leeuwen, Tetrahedron Lett. 1999, 40, 3789-3790;
45. g) M. C. Harris, O. Geis, S. L. Buchwald, J. Org. Chem. 1999, 64, 6019-6022.
46. a) R. G. Browning, H. Mahmud, V. Badarinarayana, C. J. Lovely, Tetrahedron Lett. 2001, 42, 7155-7157;
47. 2-Xantphos derivative has been utilized.
48. [6]
49. A DPPF based protocol did not qualify as an alternative, as it was only established for aminations of sterically unhindered aryl bromides (that is, no ortho substitution): G. Mann, J. F. Hartwig, M. S. Driver, C. Fernandez-Rivas, J. Am. Chem. Soc. 1998, 120, 827-828.
50. 4; see: J. C. Antilla, J. M. Baskin, T. E. Barder, S. L. Buchwald, J. Org. Chem. 2004, 69, 5578-5587.
51. A further possibility for such a conversion might be a copper catalyzed reaction, even though only established for iodoarenes in combination with similar amine substrates; see ref.[7]
52. [24]
53. [13,16]
54. a) O. Prien, ChemBioChem. 2005, 6, 500-505;
55. b) T. L. Underiner, B. Ruggeri, D. E. Gingrich, Curr. Med. Chem. 2004, 11, 731-745;
56. c) M. E. M. Noble, J. A. Endicott, L.N. Johnson, Science 2004, 303, 1800-1805;
57. d) A. Huwe, R. Mazitschek, A. Giannis, A. Angew. Chem. 2003, 115, 2170-2187;
58. Angew. Chem. Int. Ed. 2003, 42, 2122-2138;
59. e) A. J. Bridges, Chem. Rev. 2001, 107, 2541-2571.
60. For selected examples, see: a) T. Kumagai, T. Okubo, H. Kataoka-Okubo, S. Chaki, S. Okuyama, A. Nakazato, Bioorg. Med. Chem. 2001, 9, 1349-1355;
61. b) G. A. Breault, R. P. A. Elision, S. Green, S. R. James, P.J. Jewsbury, C. J. Midgley, R. A. Pauptit, C. A. Minshull, J. A. Tucker, J. E. Pease, Bioorg. Med. Chem. Lett. 2003, 13, 2961-2966;
62. c) I. R. Hardcastle, C. E. Arris, J. Bentley, F. T. Boyle, Y. Chen, N. J. Curtin, J. A. Endicott, A. E. Gibson, B. T. Golding, R. J. Griffin, P. Jewsbury, J. Menyerol, V. Mesguiche, D. R. Newell, M. E. M. Noble, D. J. Pratt, L.-Z. Wang, H. J. Whitfield, J. Med. Chem. 2004, 47, 3710-3722;
63. d) S. Verma, D. Nagarathnam, J. Shao, L. Zhang, J. Zhao, Y. Wang, T. Li, E. Mull, I. Enyedy, C. Wang, Q. Zhu, M. Altieri, J. Jordan, T.-T.-A. Dang, S. Reddy, Bioorg. Med. Chem. Lett. 2005, 15, 1973 -1977.
64. S. Wagaw, S. L. Buchwald, J. Org. Chem. 1996, 61, 7240-7241.
65. Only small quantities of starting 4-chloroquinazoli'ne were detected by LC-MS to have lost the acetyl group.
66. Recently, similar conversions were published to be accomplished successfully using bulky electron-rich biaryl pjlosphine ligands: M. D. Charles, P. Schultz, S. L. Buchwald, Org. Lett. 2005, 7, 3965-3968.
67. Y. Dong, J. Y. Roberge, Z. Wang, X. Wang, J. Tamasi, V. Dell, R. Golla, J. R. Corte, Y. Liu, T. Fang, M. N. Anthony, D. M. Schnur, M. L. Agier, J. K. Dickson Jr. R. M. Lawrence, M. M. Prack, R. Seethala, J. H. M. Feyen, Steroids 2004, 69, 201-217.